
The use of immune modulator therapeutics, a type of immunotherapy enhancing the body immune system response to cancer, was perceived as the beginning of a new era in cancer care. While still important and frequently used, some of these therapeutics produce uneven response rates, disease resistance, and serious side effects. The National Academies National Cancer Policy Forum, in collaboration with the Forum on Drug Discovery, Development, and Translation, hosted a public workshop to discuss challenges related to immunotherapy treatment resistance, as well as potential policy opportunities to improve the development of immunotherapies for cancer treatment.
Achetez cet ebook et obtenez-en 1 de plus GRATUITEMENT !
Langue Anglais ● Format EPUB ● Pages 86 ● ISBN 9780309716291 ● Éditeur Anne Frances Johnson & Erin Balogh ● Maison d’édition National Academies Press ● Publié 2024 ● Téléchargeable 3 fois ● Devise EUR ● ID 9995925 ● Protection contre la copie Adobe DRM
Nécessite un lecteur de livre électronique compatible DRM